Lamictal 200 mg Tabletten (kaubar/suspendierbar)
Recall
|
Medicines
|
30/11/2023
The marketing authorisation holder informed its customers on Nov 29, 2023 that the tablets cannot be removed as intended due to the label applied to the blister. For this reason, the mentioned batches are being recalled as a precautionary measure.
Name of the medicinal product | Lamictal 200 mg Tabletten (kaubar/suspendierbar) |
---|---|
Marketing authorisation number(s) | 1-20216-P3 |
CIP code | 4963439 |
Marketing authorisation holder | EurimPharm Vertriebs-GmbH & Co KG |
Batch number(s) | Batch, Expiry Date 72PJ, 30.09.2025 7VC5, 28.02.2026 |
Classification of the recall | 2 |
Depth of recall | Pharmacies |
BASG reference number | INS-640.001-4552 |
Further inquiry note
Page last modified:
30/11/2023